Merck Millipore launched after $7bn takover
Germany’s Merck KGaA has completed its $7bn (€b5.2n) acquisition of Millipore, unveiling plans to target “high-growth, high-margin” bio-research and bio-production markets.
Archives for July 18, 2010
ViiV opens HIV portfolio to generics firms
GSK and Pfizer’s ViiV Healthcare JV says it will make its entire drug portfolio available to generics manufacturers and 80 per cent the global HIV-infected population.
Azopharma equipment being auctioned
Pharmaceutical pilot process and laboratory equipment from three Azopharma sites is being auctioned next month.
A new leader at PhRMA and KV replacing its CFO after three months in the job – People on the move
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including a new leader at PhRMA and KV replacing its CFO after three months in the job.
Penn & Xcelience partner to offer Xcelodose to Asia, EU
Penn Pharma and Xcelience have formed an Xcelodose-focused joint venture to meet client demand in Europe and Asia for powder-in-capsule (PIC) services.
Jana says Wuxi deal offers inadequate returns for CRL
Major Charles River Laboratories (CRL) shareholder Jana Partners says Wuxi PharmaTech deal would generate inadequate returns, citing “industry” concerns about integration.
Gentronix raises funds to boost genotoxicity offering
Gentronix has raised funds to expand its portfolio of cell-based assays and strengthen its position in the European genotoxicity services market.